130 related articles for article (PubMed ID: 37993104)
21. Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1.
Koebis M; Ohsawa N; Kino Y; Sasagawa N; Nishino I; Ishiura S
Genes Cells; 2011 Sep; 16(9):961-72. PubMed ID: 21794030
[TBL] [Abstract][Full Text] [Related]
22. [Misregulation of alternative splicing and microRNA processing in DM1 pathogenesis].
Furling D
Rinsho Shinkeigaku; 2012; 52(11):1018-22. PubMed ID: 23196502
[TBL] [Abstract][Full Text] [Related]
23. Macroscopic and microscopic diversity of missplicing in the central nervous system of patients with myotonic dystrophy type 1.
Furuta M; Kimura T; Nakamori M; Matsumura T; Fujimura H; Jinnai K; Takahashi MP; Mochizuki H; Yoshikawa H
Neuroreport; 2018 Feb; 29(3):235-240. PubMed ID: 29381654
[TBL] [Abstract][Full Text] [Related]
24. Altered mRNA splicing of dystrophin in type 1 myotonic dystrophy.
Nakamori M; Kimura T; Fujimura H; Takahashi MP; Sakoda S
Muscle Nerve; 2007 Aug; 36(2):251-7. PubMed ID: 17487865
[TBL] [Abstract][Full Text] [Related]
25. The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicing.
Ravel-Chapuis A; Bélanger G; Yadava RS; Mahadevan MS; DesGroseillers L; Côté J; Jasmin BJ
J Cell Biol; 2012 Mar; 196(6):699-712. PubMed ID: 22431750
[TBL] [Abstract][Full Text] [Related]
26. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy.
Bisset DR; Stepniak-Konieczna EA; Zavaljevski M; Wei J; Carter GT; Weiss MD; Chamberlain JR
Hum Mol Genet; 2015 Sep; 24(17):4971-83. PubMed ID: 26082468
[TBL] [Abstract][Full Text] [Related]
28. Systemic Evaluation of Chimeric LNA/2'-O-Methyl Steric Blockers for Myotonic Dystrophy Type 1 Therapy.
Christou M; Wengel J; Sokratous K; Kyriacou K; Nikolaou G; Phylactou LA; Mastroyiannopoulos NP
Nucleic Acid Ther; 2020 Apr; 30(2):80-93. PubMed ID: 31873063
[TBL] [Abstract][Full Text] [Related]
29. Quantitative Methods to Monitor RNA Biomarkers in Myotonic Dystrophy.
Wojciechowska M; Sobczak K; Kozlowski P; Sedehizadeh S; Wojtkowiak-Szlachcic A; Czubak K; Markus R; Lusakowska A; Kaminska A; Brook JD
Sci Rep; 2018 Apr; 8(1):5885. PubMed ID: 29651162
[TBL] [Abstract][Full Text] [Related]
30. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy.
Du H; Cline MS; Osborne RJ; Tuttle DL; Clark TA; Donohue JP; Hall MP; Shiue L; Swanson MS; Thornton CA; Ares M
Nat Struct Mol Biol; 2010 Feb; 17(2):187-93. PubMed ID: 20098426
[TBL] [Abstract][Full Text] [Related]
31. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
Dansithong W; Paul S; Comai L; Reddy S
J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
[TBL] [Abstract][Full Text] [Related]
32. Proteogenomics Reveals Orthologous Alternatively Spliced Proteoforms in the Same Human and Mouse Brain Regions with Differential Abundance in an Alzheimer's Disease Mouse Model.
da Silva EMG; Santos LGC; de Oliveira FS; Freitas FCP; Parreira VDSC; Dos Santos HG; Tavares R; Carvalho PC; Neves-Ferreira AGDC; Haibara AS; de Araujo-Souza PS; Dias AAM; Passetti F
Cells; 2021 Jun; 10(7):. PubMed ID: 34201730
[TBL] [Abstract][Full Text] [Related]
33. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
[TBL] [Abstract][Full Text] [Related]
34. Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes.
Santoro M; Piacentini R; Masciullo M; Bianchi ML; Modoni A; Podda MV; Ricci E; Silvestri G; Grassi C
Neuropathol Appl Neurobiol; 2014 Jun; 40(4):464-76. PubMed ID: 23888875
[TBL] [Abstract][Full Text] [Related]
35. An Overview of Circular RNAs and Their Implications in Myotonic Dystrophy.
Czubak K; Sedehizadeh S; Kozlowski P; Wojciechowska M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500099
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of Staufen1 in DM1 mouse skeletal muscle exacerbates dystrophic and atrophic features.
Crawford Parks TE; Marcellus KA; Péladeau C; Jasmin BJ; Ravel-Chapuis A
Hum Mol Genet; 2020 Aug; 29(13):2185-2199. PubMed ID: 32504084
[TBL] [Abstract][Full Text] [Related]
37. Transcriptome Analysis Reveals Altered Inflammatory Pathway in an Inducible Glial Cell Model of Myotonic Dystrophy Type 1.
Azotla-Vilchis CN; Sanchez-Celis D; Agonizantes-Juárez LE; Suárez-Sánchez R; Hernández-Hernández JM; Peña J; Vázquez-Santillán K; Leyva-García N; Ortega A; Maldonado V; Rangel C; Magaña JJ; Cisneros B; Hernández-Hernández O
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33530452
[TBL] [Abstract][Full Text] [Related]
38. Misregulation of calcium-handling proteins promotes hyperactivation of calcineurin-NFAT signaling in skeletal muscle of DM1 mice.
Ravel-Chapuis A; Bélanger G; Côté J; Michel RN; Jasmin BJ
Hum Mol Genet; 2017 Jun; 26(12):2192-2206. PubMed ID: 28369518
[TBL] [Abstract][Full Text] [Related]
39. Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2.
Botta A; Vallo L; Rinaldi F; Bonifazi E; Amati F; Biancolella M; Gambardella S; Mancinelli E; Angelini C; Meola G; Novelli G
Gene Expr; 2007; 13(6):339-51. PubMed ID: 17708420
[TBL] [Abstract][Full Text] [Related]
40. The Dimeric Form of 1,3-Diaminoisoquinoline Derivative Rescued the Mis-splicing of Atp2a1 and Clcn1 Genes in Myotonic Dystrophy Type 1 Mouse Model.
Matsumoto J; Nakamori M; Okamoto T; Murata A; Dohno C; Nakatani K
Chemistry; 2020 Nov; 26(63):14305-14309. PubMed ID: 32449537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
